Deciphering and reversing the consequences of mitochondrial DNA damage
Mitochondrial DNA (mtDNA) encodes several proteins playing key roles in bioenergetics. Pathological mutations of mtDNA can be inherited or may accumulate following treatment for viral infections or cancer. Furthermore, many organi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
IlluMitoDNA
Illuminating the mechanisms of mitochondrial DNA quality con...
2M€
Cerrado
MitoRepairosome
Dissecting the mechanism of DNA repair in human mitochondria
2M€
Cerrado
BFU2015-63714-R
CARACTERIZACION A NIVEL DE MOLECULAS INDIVIDUALES DE LA DINA...
169K€
Cerrado
CYNAMIS
Clonal dynamics and mitochondrial dysfunction in hematopoies...
190K€
Cerrado
BFU2013-45182-P
REGULACION DE LA INTEGRIDAD DEL GENOMA: REPLICACION Y RECOMB...
194K€
Cerrado
SAF2009-08007
GENOMICA FUNCIONAL DEL SISTEMA OXPHOS
565K€
Cerrado
Información proyecto RevMito
Duración del proyecto: 60 meses
Fecha Inicio: 2015-03-20
Fecha Fin: 2020-03-31
Líder del proyecto
HELSINGIN YLIOPISTO
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
1M€
Descripción del proyecto
Mitochondrial DNA (mtDNA) encodes several proteins playing key roles in bioenergetics. Pathological mutations of mtDNA can be inherited or may accumulate following treatment for viral infections or cancer. Furthermore, many organisms, including humans, accumulate significant mtDNA damage during their lifespan, and it is therefore possible that mtDNA mutations can promote the aging process.
There are no effective treatments for most diseases caused by mtDNA mutation. An understanding of the cellular consequences of mtDNA damage is clearly imperative. Toward this goal, we use the budding yeast Saccharomyces cerevisiae as a cellular model of mitochondrial dysfunction. Genetic manipulation and biochemical study of this organism is easily achieved, and many proteins and processes important for mitochondrial biogenesis were first uncovered and best characterized using this experimental system. Importantly, current evidence suggests that processes required for survival of cells lacking a mitochondrial genome are widely conserved between yeast and other organisms, making likely the application of our findings to human health.
We will study the repercussions of mtDNA damage by three different strategies. First, we will investigate the link between a conserved, nutrient-sensitive signalling pathway and the outcome of mtDNA loss, since much recent evidence points to modulation of such pathways as a potential approach to increase the fitness of cells with mtDNA damage. Second, we will explore the possibility that defects in cytosolic proteostasis are precipitated by mtDNA mutation. Third, we will apply the knowledge and concepts gained in S. cerevisiae to both candidate-based and unbiased searches for genes that determine the aftermath of severe mtDNA damage in human cells. Beyond the mechanistic knowledge of mitochondrial dysfunction that will emerge from this project, we expect to identify new avenues toward the treatment of mitochondrial disease.